Haemonetics Corporation (HAE) — Cash Flow Reinvestment Rate
Haemonetics Corporation (HAE) has a Cash Flow Reinvestment Rate of 0.25x as of March 2026, reinvesting $17.66 Million (capex $17.66 Million ) from operating cash flow of $70.94 Million. Explore Haemonetics Corporation capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Haemonetics Corporation Cash Flow Reinvestment Rate (1992–2026)
Historical reinvestment intensity for Haemonetics Corporation across 35 annual periods. Also explore Haemonetics Corporation balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Haemonetics Corporation (1992–2026)
Year-by-year capital reinvestment analysis for Haemonetics Corporation. For live market cap and broader valuation context, see HAE market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.11x | $32.78 Million | $293.22 Million | $32.78 Million | ▼ -89.9% |
| 2025 | 1.11x | $201.17 Million | $181.72 Million | $39.28 Million | ▼ -48.2% |
| 2024 | 2.14x | $388.69 Million | $181.75 Million | $66.30 Million | ▲ +129.9% |
| 2023 | 0.93x | $253.98 Million | $273.06 Million | $110.19 Million | ▼ -12.4% |
| 2022 | 1.06x | $182.85 Million | $172.26 Million | $96.51 Million | ▼ -75.0% |
| 2021 | 4.25x | $462.48 Million | $108.81 Million | $37.04 Million | ▲ +534.8% |
| 2020 | 0.67x | $105.93 Million | $158.22 Million | $48.76 Million | ▼ -54.6% |
| 2019 | 1.48x | $235.11 Million | $159.28 Million | $118.96 Million | ▲ +136.0% |
| 2018 | 0.63x | $137.84 Million | $220.35 Million | $74.80 Million | ▼ -33.1% |
| 2017 | 0.94x | $149.45 Million | $159.74 Million | $76.14 Million | ▲ +8.2% |
| 2016 | 0.86x | $105.41 Million | $121.86 Million | $102.41 Million | ▼ -10.0% |
| 2015 | 0.96x | $122.22 Million | $127.18 Million | $122.22 Million | ▲ +61.2% |
| 2014 | 0.60x | $83.19 Million | $139.52 Million | $73.65 Million | ▼ -19.7% |
| 2013 | 0.74x | $63.19 Million | $85.07 Million | $62.19 Million | ▲ +61.0% |
| 2012 | 0.46x | $53.20 Million | $115.32 Million | $53.20 Million | ▲ +22.0% |
| 2011 | 0.38x | $46.67 Million | $123.45 Million | $46.67 Million | ▼ -12.3% |
| 2010 | 0.43x | $56.30 Million | $130.67 Million | $56.30 Million | ▼ -11.1% |
| 2009 | 0.48x | $56.38 Million | $116.36 Million | $56.38 Million | ▼ -34.9% |
| 2008 | 0.74x | $57.79 Million | $77.67 Million | $57.79 Million | ▲ +50.0% |
| 2007 | 0.50x | $41.46 Million | $83.56 Million | $41.46 Million | ▲ +15.5% |
| 2006 | 0.43x | $36.77 Million | $85.62 Million | $36.77 Million | ▲ +74.5% |
| 2005 | 0.25x | $17.53 Million | $71.21 Million | $17.53 Million | ▲ +32.5% |
| 2004 | 0.19x | $13.86 Million | $74.61 Million | $13.86 Million | ▼ -40.1% |
| 2003 | 0.31x | $13.54 Million | $43.67 Million | $13.54 Million | ▼ -53.7% |
| 2002 | 0.67x | $21.60 Million | $32.24 Million | $21.60 Million | ▲ +33.9% |
| 2001 | 0.50x | $30.54 Million | $61.01 Million | $30.54 Million | ▲ +14.8% |
| 2000 | 0.44x | $23.32 Million | $53.47 Million | $23.32 Million | ▼ -34.7% |
| 1999 | 0.67x | $22.50 Million | $33.70 Million | $22.50 Million | ▼ -33.2% |
| 1998 | 1.00x | $20.40 Million | $20.40 Million | $20.40 Million | ▼ -16.6% |
| 1997 | 1.20x | $32.00 Million | $26.70 Million | $32.00 Million | ▲ +233.4% |
| 1996 | 0.36x | $19.70 Million | $54.80 Million | $19.70 Million | ▼ -77.5% |
| 1995 | 1.60x | $24.90 Million | $15.60 Million | $24.90 Million | ▲ +88.2% |
| 1994 | 0.85x | $22.90 Million | $27.00 Million | $22.90 Million | ▲ +73.0% |
| 1993 | 0.49x | $17.60 Million | $35.90 Million | $17.60 Million | ▼ -19.2% |
| 1992 | 0.61x | $11.40 Million | $18.80 Million | $11.40 Million | — |